CLDX
Celldex Therapeutics Inc
Price:  
26.51 
USD
Volume:  
924,925.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

CLDX WACC - Weighted Average Cost of Capital

The WACC of Celldex Therapeutics Inc (CLDX) is 7.0%.

The Cost of Equity of Celldex Therapeutics Inc (CLDX) is 10.40%.
The Cost of Debt of Celldex Therapeutics Inc (CLDX) is 5.00%.

Range Selected
Cost of equity 8.10% - 12.70% 10.40%
Tax rate 26.20% - 27.00% 26.60%
Cost of debt 5.00% - 5.00% 5.00%
WACC 5.9% - 8.2% 7.0%
WACC

CLDX WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.92 1.4
Additional risk adjustments 0.0% 0.5%
Cost of equity 8.10% 12.70%
Tax rate 26.20% 27.00%
Debt/Equity ratio 1 1
Cost of debt 5.00% 5.00%
After-tax WACC 5.9% 8.2%
Selected WACC 7.0%